Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth University, Katraj-Dhankawadi, Pune-Satara Road, Pune-411043, Maharashtra, India.
J Ethnopharmacol. 2013 Oct 28;150(1):215-22. doi: 10.1016/j.jep.2013.08.025. Epub 2013 Aug 27.
The rhizome of Tectaria cicutaria has been used in the folklore system of Indian traditional medicine (Ayurveda) for the treatment of various disorders such as rheumatic pain, chest complaints, burns, sprain, poisonous bites, tonsilitis, toothache, gum complaints, cuts and wounds. The present work has for the first time tried to elucidate the anti-inflammatory potential of aqueous extract of Tectaria cicutaria rhizome (TCRaq) in vitro as well as in vivo.
Anti-inflammatory potential of TCRaq was analyzed in vivo in carrageenan induced rat paw edema model. Serum antioxidant status in TCRaq-treated as well as untreated control rodents was measured by oxygen radical absorbance capacity (ORAC) assay. In vitro experiments for analyzing the anti-inflammatory potential of TCRaq were performed on murine macrophage cell line, RAW 264.7. Analysis of nitric oxide release in RAW 264.7 cells was done by Griess reaction. RT-PCR and western blotting experiment was performed to analyze the expression of iNOS. Expression of COX-2 and NFκB proteins was evaluated by western blotting.
TCRaq significantly reduced the paw volume in Sprague-Dawley rats at a dose of 200mg/kg body weight, which was comparable with the standard diclofenac treatment. The rats treated with TCRaq showed a significant increase in the serum antioxidant levels compared to the untreated control animals. TCRaq was able to reduce the nitric oxide (NO) levels in RAW 264.7 cells that had been stimulated with lipopolysaccharide (LPS). This was accompanied by a corresponding decrease in iNOS expression at mRNA and protein level. Interestingly, TCRaq was found to decrease the expression of COX-2 as well as the nuclear translocation of NFκB in RAW 264.7 cells.
Our study signifies the anti-inflammatory potential of Tectaria cicutaria and scientifically validates its traditional use in inflammatory conditions.
Tectaria cicutaria 的根茎在印度传统医学(阿育吠陀)的民间系统中被用于治疗各种疾病,如风湿痛、胸部不适、烧伤、扭伤、毒蛇咬伤、扁桃体炎、牙痛、牙龈疾病、割伤和伤口。本工作首次尝试在体外和体内阐明 Tectaria cicutaria 根茎水提物(TCRaq)的抗炎潜力。
在角叉菜胶诱导的大鼠足肿胀模型中体内分析 TCRaq 的抗炎潜力。用氧自由基吸收能力(ORAC)测定法测定 TCRaq 处理和未处理对照啮齿动物血清中的抗氧化状态。在 RAW 264.7 小鼠巨噬细胞系上进行体外实验分析 TCRaq 的抗炎潜力。通过格里斯反应分析 RAW 264.7 细胞中一氧化氮(NO)的释放。通过 RT-PCR 和 Western blotting 实验分析 iNOS 的表达。通过 Western blotting 评估 COX-2 和 NFκB 蛋白的表达。
TCRaq 在 200mg/kg 体重的剂量下可显著减少 Sprague-Dawley 大鼠的足体积,与标准双氯芬酸钠治疗相当。与未处理的对照动物相比,用 TCRaq 处理的大鼠血清抗氧化水平显著增加。TCRaq 能够降低脂多糖(LPS)刺激的 RAW 264.7 细胞中的一氧化氮(NO)水平。这伴随着 iNOS 表达在 mRNA 和蛋白水平的相应降低。有趣的是,TCRaq 被发现降低了 RAW 264.7 细胞中 COX-2 的表达以及 NFκB 的核转位。
我们的研究表明了 Tectaria cicutaria 的抗炎潜力,并从科学上验证了其在炎症情况下的传统用途。